The Dow Chemical Company

Filmtec Corporation

Nl Chemicals Technologies, Inc.

Midwest Research Institute

Northstar Research Institute, Ltd.

Nl Chemical Technology, Inc.

Queststar Medical, Inc.

Robert J Petersen

Ritchie A Wessling

Donald L Schmidt

Norman N Li

Richard F Fibiger

David J Forgach

Ja-Young Koo

Thomas F Stocker

Mark A Kuehne

John E Cadotte

Hiroshi Nomura

August R Hanson

Arthur R Kydd

Joel-Raphael Racchini

Spiral wound reverse osmosis devices with reduced lateral leakage and thereby increased salt rejection are made by compacting a microporous layer within a composite reverse osmosis membrane longitudinally along its lengthwise periphery. Means and method for causing longitudinal indentations in composite membranes during manufacturing operations are disclosed and described.

Reduced lateral leakage in reverse osmosis devices

A wicking material is disclosed that exhibits a horizontal wicking velocity of at least about 1.0 millimeter per second when contacted with a physiological fluid such as blood, lymph or cellular interstitial fluid. This high wicking rate is achieved by means of treatment of a fibrous wicking material candidate with a low temperature gas plasma, particularly a glow discharge gas plasma formed in a gaseous blend made up predominantly of a mixture of oxygen with a saturated alkane chosen from the group consisting of methane, ethane and propane. Diagnostic test strips made with the surface-modified wicking material, and containing an immobilized reagent means for analysis of an analyte in a physiological fluid, show improved performance in terms of increased accuracy, finer precision of analyses, reduced time of analysis, a smaller fluid sample size requirement, and improved compliance with manufacturing standards resulting in lower manufacturing costs blood sugar determinations.

Surface-modified wick for diagnostic test strip

Reverse osmosis membranes with improved water flux and excellent solute rejection characteristics are formed by interfacial reaction of an essentially monomeric polyamine reactant having an average of at least two amine functional groups with an essentially monomeric amine-reactive reactant having an average of at least 2.05 acyl halide functional groups, the polymerization reaction being conducted in the presence of a monohydric phenol on the surface of a porous substrate. A specific example is a high flux composite membrane prepared by coating a porous substrate with an aqueous solution containing about 0.1-20 wt % m-phenylenediamine and 0.1-9.9 wt % phenol, and interfacially contacting the coated substrate with a nonaqueous solution of about 0.01-10 wt % trimesoyl chloride for a time sufficient to form a polyamide coating, followed optionally by one or more washing and drying steps to remove the nonaqueous solvent and most or all of residual unreacted chemicals.

High flux reverse osmosis membrane

A method of separating water of reduced concentration of a selected solute via reverse osmosis, wherein the selected solute is sulfuric acid, sodium hydroxide, isopropanol, sodium nitrate or another solute having a much higher solute passage than sodium chloride. The reverse osmosis membrane is prepared by treating a crosslinked, polyamide discriminating layer with an amine-reactive reagent or compatible oxidant at conditions whereby the passage of the selected solute at a selected transmembrane pressure is reduced by at least 30 percent.

Use of treated composite polyamide membranes to separate concentrated

An improved composite polyamide membrane and methods of making the membrane are described. This improved membrane is prepared using a cationic polymeric wetting agent in an aqueous solution containing a polyfunctional amine reactant which is interfacially polymerized with an acyl halide to form a thin film polyamide discriminating layer on a microporous support. Alternatively, the wetting agent can be applied directly to the substrate and the interfacial polymerization can occur on said treated substrate. The resulting membrane exhibits an unexpected combination of high water flux, high rejection of divalent anion salts, variable sodium chloride rejection and good caustic resistance at low operating pressures. In one embodiment of this invention, a porous substrate is first treated with an aqueous piperazine solution containing a copolymer of vinylbenzyl dimethyl sulfonium chloride and methacrylic acid and then the coated microporous support is contacted with trimesoyl chloride in an organic solvent.

Novel polyamide reverse osmosis membranes

Fluoroacylation of ethyl cellulose has been found to result in good gas permeability and blood compatibility for polymeric layers made from the resulting fluorinated esters. The fluoroacylated ethyl cellulose has good hydrolytic stability at blood pH and under sterilization conditions (e.g. 100.degree. C.). For use in blood oxygenation devices, implantable biomedical devices, blood sampling of analysis or purification devices, etc., it is preferred that the fluoroacylated ethyl cellulose be substantially free of residual OH and have a fluorine content above 10% by weight (e.g. at least about 12% by weight).

Blood compatible polymers and applications thereof

Fluoroacylation of ethyl cellulose has been found to result in good gas permeability and blood compatibility for polymeric layers made from the resulting fluorinated esters. The fluoroacylated ethyl cellulose has good hydrolytic stability at blood pH and under sterilization conditions (e.g. 100.degree. C). For use in blood oxygenation devices, implantable biomedical devices, blood sampling or analysis or purification devices, etc., it is preferred that the fluoroacylated ethyl cellulose be substantially free of residual OH and have a fluorine content above 10% by weight (e.g. at least about 12% by weight).

Blood compatible polymers for blood oxygenation devices

Growing community of inventors

Minneapolis, MN, United States of America

Robert J Petersen